Found: 86
Select item for more details and to access through your institution.
Reply to van der Sar et al. : Classifying Interstitial Lung Disease: Omics Are in the Air.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 5, p. 639, doi. 10.1164/rccm.202310-1887OC
- By:
- Publication type:
- Article
Transcriptome-Wide Association Study of Idiopathic Pulmonary Fibrosis Survival Identifies PTPN9 and SNRPB2.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 5, p. 683, doi. 10.1164/rccm.202310-1741LE
- By:
- Publication type:
- Article
CT findings associated with survival in chronic hypersensitivity pneumonitis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Author Correction: PEAR1 regulates expansion of activated fibroblasts and deposition of extracellular matrix in pulmonary fibrosis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Expression profiling elucidates a molecular gene signature for pulmonary hypertension in sarcoidosis.
- Published in:
- Pulmonary Circulation, 2016, v. 6, n. 4, p. 465, doi. 10.1086/688316
- By:
- Publication type:
- Article
Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis.
- Published in:
- FASEB Journal, 2013, v. 27, n. 4, p. 1749, doi. 10.1096/fj.12-219634
- By:
- Publication type:
- Article
Reply to Ward et al. : Integrating Aerodigestive Investigations in Progressive Pulmonary Fibrosis.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 4, p. 455, doi. 10.1164/rccm.202402-0339OC
- By:
- Publication type:
- Article
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 4, p. 401, doi. 10.1164/rccm.202401-0238SO
- By:
- Publication type:
- Article
The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 4, p. 392, doi. 10.1164/rccm.202401-0048PP
- By:
- Publication type:
- Article
Reply to Fujimoto et al. : Leveraging Microbiome Composition Variability for Precision Medicine in Idiopathic Pulmonary Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 4, p. 528, doi. 10.1164/rccm.202312-2262LE
- By:
- Publication type:
- Article
TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 4, p. 508, doi. 10.1164/rccm.202312-2224LE
- By:
- Publication type:
- Article
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 4, p. 444, doi. 10.1164/rccm.202309-1692OC
- By:
- Publication type:
- Article
Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 9, p. 1101, doi. 10.1164/rccm.202308-1357OC
- By:
- Publication type:
- Article
Reply to Spek and Duitman.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 207, n. 12, p. 1644, doi. 10.1164/rccm.202303-0402LE
- By:
- Publication type:
- Article
N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis.
- Published in:
- Annals of the American Thoracic Society, 2023, v. 20, n. 12, p. 1683, doi. 10.1513/AnnalsATS.202303-188PS
- By:
- Publication type:
- Article
Associations of D-Dimer with Computed Tomographic Lung Abnormalities, Serum Biomarkers of Lung Injury, and Forced Vital Capacity: MESA Lung Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and Methods.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography.
- Published in:
- 2018
- By:
- Publication type:
- letter
Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis.
- Published in:
- JAMA: Journal of the American Medical Association, 2013, v. 309, n. 21, p. 2232, doi. 10.1001/jama.2013.5827
- By:
- Publication type:
- Article
Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study of Aerosolized Interferon Gamma-1b in Patients With Mild to Moderate Cystic Fibrosis Lung DiseaseOur results were presented in part at the American Thoracic Society 2003 Annual Meeting (Moss et al., Am J Respir Crit Care Med 2003;167:923).Conflict of interest statement: Karen Starko, M.D., is an employee of Intermune, Inc., which partly sponsored this study, provided study agents, and participated in data analysis.
- Published in:
- Pediatric Pulmonology, 2005, v. 39, n. 3, p. 209, doi. 10.1002/ppul.20152
- By:
- Publication type:
- Article
Short duration exercise increases breath hydrogen excretion after lactulose ingestion: description of a new phenomenon
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2002, v. 97, n. 11, p. 2798, doi. 10.1111/j.1572-0241.2002.07025.x
- By:
- Publication type:
- Article
Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial.
- Published in:
- BMC Pulmonary Medicine, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12890-022-02281-8
- By:
- Publication type:
- Article
Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0044818
- By:
- Publication type:
- Article
The HLA Class II Allele DRB1*1501 Is Over-Represented in Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- PLoS ONE, 2011, v. 6, n. 2, p. 1, doi. 10.1371/journal.pone.0014715
- By:
- Publication type:
- Article
When Is It More Than Just a Spicy Meal?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Interstitial Pneumonia With Autoimmune Features.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2017, v. 141, n. 7, p. 960, doi. 10.5858/arpa.2016-0427-OA
- By:
- Publication type:
- Article
Pathologic Quantification of Connective Tissue Disease--Associated Versus Idiopathic Usual Interstitial Pneumonia.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2012, v. 136, n. 10, p. 1253, doi. 10.5858/arpa.2012-0102-OA
- By:
- Publication type:
- Article
A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Erratum: The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes.
- Published in:
- Scientific Reports, 2017, p. 46860, doi. 10.1038/srep46860
- By:
- Publication type:
- Article
The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes.
- Published in:
- Scientific Reports, 2017, p. 46560, doi. 10.1038/srep46560
- By:
- Publication type:
- Article
PEAR1 regulates expansion of activated fibroblasts and deposition of extracellular matrix in pulmonary fibrosis.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34870-w
- By:
- Publication type:
- Article
Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 205, p. 1, doi. 10.1126/scitranslmed.3005964
- By:
- Publication type:
- Article
Idiopathic Pulmonary Fibrosis Genetic Risk Factors, Function, and Mechanisms? The Concepts Are Starting to Gel.
- Published in:
- 2022
- By:
- Publication type:
- editorial
Genome-wide Enrichment of TERT Rare Variants in Idiopathic Pulmonary Fibrosis Patients of Latino Ancestry.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 206, n. 7, p. 903, doi. 10.1164/rccm.202203-0622LE
- By:
- Publication type:
- Article
Toll-Interacting Protein and Altered Lung Microbiota in Idiopathic Pulmonary Fibrosis.
- Published in:
- 2022
- By:
- Publication type:
- letter
Rare and Common Variants in Contribute to Genetic Risk of Idiopathic Pulmonary Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 206, n. 1, p. 56, doi. 10.1164/rccm.202110-2439OC
- By:
- Publication type:
- Article
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European Populations.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European Populations.
- Published in:
- 2021
- By:
- Publication type:
- letter
Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Bloom Is in Bud for Interstitial Lung Diseases.
- Published in:
- 2020
- By:
- Publication type:
- editorial
Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease.
- Published in:
- 2020
- By:
- Publication type:
- letter
Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article